The Current Ratio as of November 2024 (TTM) for Arch Therapeutics, Inc. (ARTH) is 0.10

According to Arch Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.10. This represents a change of -32.24% compared to the average of 0.15 of the last 4 quarters.

Arch Therapeutics, Inc. (ARTH) Historical Current Ratio (quarterly & annually)

How has ARTH Current Ratio performed in the past?

The mean historical Current Ratio of Arch Therapeutics, Inc. over the last ten years is 4.74. The current 0.10 Current Ratio has changed 110.34% with respect to the historical average. Over the past ten years (40 quarters), ARTH's Current Ratio was at its highest in in the March 2017 quarter at 20.88. The Current Ratio was at its lowest in in the June 2024 quarter at 0.10.

Arch Therapeutics, Inc. (ARTH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Arch Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arch Therapeutics, Inc. (ARTH) Average Current Ratio

How has ARTH Current Ratio performed in the past?

The current Current Ratio of Arch Therapeutics, Inc. (ARTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Arch Therapeutics, Inc. (ARTH) Current Ratio vs. Peers

How is ARTH’s Current Ratio compared to its peers?

Arch Therapeutics, Inc.’s Current Ratio is greater than Bioasis Technologies Inc. (0), less than Antibe Therapeutics Inc. (10.06), less than Awakn Life Sciences Corp. (0.35), less than Cellectis S.A. (1.78), less than Adynxx, Inc. (0), greater than AVAX Technologies, Inc. (0), less than BioCardia, Inc. (1.61), less than Adial Pharmaceuticals, Inc. WT EXP 073123 (1.78), less than null (6.78),

Build a custom stock screener for Arch Therapeutics, Inc. (ARTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arch Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arch Therapeutics, Inc. (ARTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arch Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.